Skip to main content
Premium Trial:

Request an Annual Quote

Fitch Assigns BBB Rating to Quest's Senior Notes Offering

NEW YORK (GenomeWeb) – Fitch Ratings has assigned a BBB rating to the $1.2 billion senior notes offering announced today by Quest Diagnostics. 

Fitch also said the rating outlook is stable. It said in a statement that the refinancing will raise Quest's debt leverage this year to be temporarily elevated but that it anticipates the debt to be repaid and Quest's total debt balances to be reduced to about $3.8 billion by the end of the year. 

Quest said that it will use the proceeds from the offering to fund the purchase of up to $250 million in combined aggregate principal amount of its 6.95 percent senior notes due 2037 and its 5.75 percent senior notes due 2040. In addition, it intends to redeem all $500 million of its outstanding 5.45 percent senior notes due 2015; all $375 million of its outstanding 6.4 percent senior notes due 2017; and $150 million, or 50 percent, of its outstanding 3.2 percent senior notes due 2016.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.